Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04837963
Other study ID # RECHMPL21_0225
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 16, 2021
Est. completion date July 30, 2021

Study information

Verified date October 2021
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Febrile urinary tract infection (FUTIs) are the most common bacterial infections in children under the age of 2 years. They represent 7% of children presenting with fever without a source. In case of recurrent or undertreated FUTIs there is a risk for kidney function with the threat of chronic renal failure [7]. They are more often isolated but some FUTIs may reveal an underlying and facilitating condition. Beside the well-known congenital anomalies of the kidneys and urinary tract such as reflux or obstructions, others risk factors for FUTI are reported. Age less than 1 year, uncircumcised males, poor fluid intake, bladder bowel dysfunction (BBD) including dysfunctional voiding pattern and constipation increase the risk of FUTI. The prevalence of BBD in children with FUTIs is far higher than in the general population. Recommendations emphasize on an efficient treatment of BBD in the first-line management of recurring FUTIs and it has been proven to be efficient (ref). One of the BBD may include Hirschsprung's Disease (HD). HD is the first congenital malformation of the enteric nervous system with a reported prevalence of 1 in 5000 live birth. It's characterized by an aganglionosis and subsequent dysmotility affect by always the anal canal, most commonly there is a rectosigmoid form (74-80%), and less commonly involves a long segment of colon (12-22%) or a total colonic aganglionosis with ileal involvement upto 50 cm proximal to ileocecal junction (4-13%). The treatment is based on the resection of dysfunctional segment of colon with an anastomosis between the normally innervated bowel to the anus, while preserving normal sphincter function. But significant bowel dysfunction may persist postoperatively. 20% of the children present a fecal incontinence, and 14% a constipation in long-term studies. Bladder dysfunction and associated urological anomalies are also reported in these patients. All of that may facilitate the occurrence of febrile urinary tract infections (FUTI) in patients with HD. Unfortunately, few studies focused on this specific population. The objective of this study was to find out whether children with HD are more prone to develop FUTIs than controls and which patient with HD are more at risk to develop UTIs.


Recruitment information / eligibility

Status Completed
Enrollment 630
Est. completion date July 30, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion criteria: Patients : - surgical treatment of an HD confirmed on histopathologic exam. Controls : - appendicetomy for acute appendicitis without history of HD, ano rectal malformation or any other colic disease Exclusion criteria: - patients with HD but not yet operated - patient with a stoma at the time of the study - patient with chronic intestinal pseudo obstruction without HD

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France University hospital of Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare the risk of febril urinary tract infection Compare the risk of febril urinary tract infection between children with Hirschsprung disease and control Febrile urinary tract infection was defined as a positive urine examination with a single bacteria with more than 10.5 cfu/mL and more than 10.4 leukocytes/ml associated with fever above 38.5°C and C-reactive protein (CRP) above 50 mg/ Day 1
Secondary Compare the age at the time of febrile urinary tract infection Compare the age at the time of febrile urinary tract infection between children with Hirschsprung disease and control. This event could occur sooner in children with Hirschsprung disease than controls. Day 1
Secondary Febrile urinary tract infection risk factor Febrile urinary tract infection risk factor for children with Hirschsprung disease based upon the form of the disease, kinf of surgery, functional results For each patient treated by Hirschsprung disease, surgical technique, the level of involvement and the functional outcome will be collected.
The functional outcome was evaluated through the number of stool per day, the presence of soiling, the need of additional antegrade or retrograde colonic enema
Day 1
See also
  Status Clinical Trial Phase
Completed NCT00630838 - Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC) Phase 2
Not yet recruiting NCT03269812 - Laparoscopic Assisted Pull-through Versus Other Surgical Procedures for Treatment of Hirschsprung Disease N/A
Recruiting NCT02343562 - Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis Phase 4
Completed NCT01985646 - A Trial on Conservative Treatment for Infants' Hirschsprung Disease Phase 0
Completed NCT01515501 - Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial) N/A
Enrolling by invitation NCT04150120 - eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness N/A
Completed NCT03666767 - Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
Recruiting NCT04149093 - The Association Between Calretinin and the Function of Ganglion Cells in Hirschsprung Disease
Recruiting NCT04622410 - Registry for Hirschsprung Disease of the BELAPS
Completed NCT04020939 - The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. N/A
Completed NCT05038345 - Hirschsprung Disease Trends
Recruiting NCT06072976 - The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies N/A
Recruiting NCT05293353 - Neokare Safety and Tolerability Assessment in Neonates With GI Problems
Completed NCT02857205 - MICROPRUNG : Intestinal Microbiota Analysis in Patients With or Without Hirschsprung's Associated EnteroColitis N/A
Recruiting NCT04904081 - Feasibility of Use of Indocyanine Green in Pediatric Colorectal Surgery Phase 3
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT04730128 - Translation and Validation of a Disease-specific Questionnaire for Hirschsprung's Disease in Danish Patients
Recruiting NCT05450991 - Long-term Qualitative and Quantitative Outcomes of Children With Hirschsprung's Disease and Anorectal Malformations
Recruiting NCT02776176 - Enhanced Recovery After Surgery In Hirschsprung Disease N/A
Recruiting NCT02216994 - A New Scoring System Improves Diagnostic Accuracy of Intestinal Dysganglionosis --a Prospective Study N/A